Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ELI LILLY & Co | EVP & Pres, Lilly Neuroscience | Common Stock | 65.6K | $48.3M | $737.26 | Feb 12, 2024 | Direct |
ELI LILLY & Co | EVP & Pres, Lilly Neuroscience | Restricted Stock Unit | 3.27K | $2.41M | $737.26 | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LLY | ELI LILLY & Co | Feb 12, 2024 | 2 | $3.95M | 4 | Feb 14, 2024 | EVP & Pres, Lilly Neuroscience |
LLY | ELI LILLY & Co | Feb 1, 2024 | 3 | -$1.19M | 4 | Feb 2, 2024 | EVP & Pres, Lilly Neuroscience |
LLY | ELI LILLY & Co | Feb 10, 2023 | 4 | $1.23M | 4 | Feb 14, 2023 | EVP & Pres, Lilly Neuroscience |
LLY | ELI LILLY & Co | Feb 1, 2023 | 3 | -$1.12M | 4 | Feb 3, 2023 | EVP & Pres, Lilly Neuroscience |
LLY | ELI LILLY & Co | Feb 9, 2022 | 2 | $2.76M | 4 | Feb 11, 2022 | SVP & Pres-Lilly Neuroscience |
LLY | ELI LILLY & Co | Feb 1, 2022 | 3 | -$1.03M | 4 | Feb 3, 2022 | SVP & Pres-Lilly Neuroscience |